Results 171 to 180 of about 10,214,758 (341)

Does Green Brazilian Propolis Extract Improve Functional Capacity in Symptomatic Chronic Coronary Disease?-A Pilot Randomized Trial. [PDF]

Pharmaceuticals (Basel)
Figueiredo CS, Passos LCS, Cafezeiro CRF, de Melo RMV, Viana TT, de Oliveira EJG, Berretta AA, Silveira MAD.   +7 more
europepmc   +1 more source

Serum Mucoproteins and Plasma Fibrinolytic Activity in Coronary-artery Disease [PDF]

, 1962
D. Ogston
openalex   +1 more source

Activation of Spinal Astrocyte α2A Adrenoceptors Protects Against Sepsis‐Induced Heart Injury Through Inhibition of GABAergic Neuronal Necroptosis

Advanced Science, EarlyView.
The study in this paper found that activating the α2A receptors of astrocytes in the thoracic spinal cord can reduce the release of inflammatory factors, thereby decreasing the necroptosis of GABAergic neurons and consequently alleviating myocardial injury caused by sepsis.
Ruilin He, Bin Wu, Liuhu Han, Mingde Li, Wenli Guo, Jiajing Fu, Bin Mei, Eric R. Gross, Xuesheng Liu, Yao Lu   +9 more
wiley   +1 more source

Risk Factors Associated With Coronary Disease in Saudi Arabia: A Comprehensive Review. [PDF]

Cureus
Alsuheimy AA, Aljuaid AB, Albalawi FN, Hassounah E, Modahi F, Alkhurayji K.   +5 more
europepmc   +1 more source

A Longitudinal Study Reveals Metabolomic Markers for Individuals at Risk, Disease Severity, and Treatment Response in Rheumatoid Arthritis

Advanced Science, EarlyView.
This study investigates plasma metabolomic biomarkers for rheumatoid arthritis (RA) development using longitudinal data from 209 RA patients and 56 individuals at risk. It also reveals metabolic signatures linked to severity, age, sex, and anti‐citrullinated protein autoantibody in RA.
Chenxi Zhu, Jiayi Xu, Siyu He, Qian Niu, Yi Liu, Xin Guo, Huifang Hu, Rui Sun, Tao Chen, Yan Liu, Zhiqiang Xu, Na Jiang, Lipu Yao, Lunzhi Dai, Qinghua Zou, Fanxin Zeng, Liesu Meng, Inger Gjertsson, Rikard Holmdahl, Bin Yang, Dan Du, Yi Zhao   +21 more
wiley   +1 more source

Minimally invasive coronary bypass grafting for treating multivessel coronary disease: A single-center prospective pilot study. [PDF]

JTCVS Open
Ding T, Gong Y, Fu Y, Cui Z, Wu S, Yang W, Yang H, Zhao H, Feng H, Zheng H, Meng L, Guo R, Han H, Ling Y.   +13 more
europepmc   +1 more source

SURGICAL TREATMENT OF CORONARY HEART DISEASE

, 1958
ชิน บูรณธรรม
openalex   +2 more sources

Explaining the decrease in U.S. deaths from coronary disease, 1980-2000.

New England Journal of Medicine, 2007
E. Ford, U. Ajani, J. Croft, J. Critchley, D. Labarthe, T. Kottke, W. Giles, S. Capewell   +7 more
semanticscholar   +1 more source

ER‐phagy Activation by AMFR Attenuates Cardiac Fibrosis Post‐Myocardial Infarction via mTORC1 Pathway

Advanced Science, EarlyView.
By catalyzing FAM134B ubiquitination and activating ER‐phagy, AMFR alleviates progressive fibrosis and cardiac dysfunction by inhibiting the mTORC1 pathway. Consequently, these findings underscore the essential role of AMFR‐driven ER‐phagy in mitigating the progression of fibrotic responses, offering a potential therapeutic target for preventing heart ...
Zhixiang Wang, Kaifan Niu, Wei Liu, Xinyun Wang, Boshen Yang, Taixi Li, Yizhi Chen, Yuanyuan Jin, Yu Chen, Yangyi Lin, Xian Jin   +10 more
wiley   +1 more source

Corrigendum to “The “L-Sandwich” Strategy for True Coronary Bifurcation Lesions: A Randomized Clinical Trial”

Journal of Interventional Cardiology
Quan Guo, Liang Peng, Lixin Rao, Cao Ma, Kang Zhao, Zhenzhou Zhao, Haiyu Tang, Muwei Li   +7 more
doaj   +1 more source